A second dose of tetanus-diphtheria-acellular pertussis vaccine (Tdap), given to adults 10 years after the initial dose, is both safe and effective, according to a randomized controlled trial that included 1,330 adults between ages 18 and <65 years. Among the findings:
- Investigators gave either Tdap or tetanus-diphtheria (Td) vaccine to patients aged 8-12 years after a previous Tdap dose had been given and tracked adverse effects.
- There were no significant differences in injection site reactions, systemic reactions, or serious adverse reactions between the 2 vaccine groups.
- Antibody responses to each pertussis antigen in Tdap vaccinated groups were documented.
- Postvaccination tetanus antibody concentrations and diphtheria antibody concentrations were similar for Tdap and Td groups.
- Seroprotection against tetanus and diphtheria was ~99% in both groups.
Halperin SA, Donovan C, Marshall GS, et al. Randomized controlled trial of the safety and immunogenicity of revaccination with tetanus-diphtheria-acellular pertussis vaccine (Tdap) in adults 10 years after a previous dose. [Published online ahead of print February 8, 2018]. J Pediatr Infect Dis Soc. doi:10.1093/jpids/pix113.
This Week's Must Reads
Do Vitamin D Supplements Prevent Cancer, CVD?, N Engl J Med; 2019 Jan 3; Manson, Cook, et al
Nonadherence to Cancer Screenings & Related Mortality, JAMA Intern Med; ePub 2018 Dec 28; Pierre-Victor, et al
Alcohol Consumption After Development of HF, JAMA Netw Open; ePub 2018 Dec 28; Sadhu, et al
Opioid-Involved Overdose Deaths in the US, MMWR; 2019 Jan 4; Scholl, Seth, et al
Assessing the Diet Quality of US Children, Am J Clin Nutrit; ePub 2018 Dec 29; Thomson, et al
Must Reads in Vaccines
AAP Revision on Dismissing Vaccine-Refusing Families, JAMA Pediatr; ePub 2018 Apr 30; Deem, et al
Creating Preventive Vaccines for Lynch Syndrome, JAMA Oncology; ePub 2018 Apr 16; Chang, et al
Children with Autism Less Likely to Be Vaccinated, JAMA Pediatr; ePub 2018 Mar 26; Zerbo, et al
Antibody-Based Vaccines & Intracellular Pathogens, Curr Opin Immunol; ePub 2018 Apr 25; Casadevall
Designing an Effective Hepatitis C Vaccine, Trends Microbiol; ePub 2018 Apr 24; Kinchen, et al